Right-Size Team of Senior ClinOps Professionals for Small and Mid-Size Oncology Sponsors

Choice ClinOps functions as the central hub for clinical operations, catering to small and midsize companies involved in high-risk, high-value oncology programs (with added rare disease and cell and gene therapy expertise) on both local and global scales. As a prominent fractional service provider, we extend the sponsor team when internal bandwidth is limited or specialized clinical operations expertise is required. In scenarios where visibility wanes, vendors fall out of alignment, or sites underperform—especially during significant transitions such as mergers, acquisitions, or changes in CRO/large vendor partnerships—Choice ClinOps intervenes to maintain seamless continuity. Led by Leila Cupersmith, our fractional clinical operations model not only enhances control and accelerates execution but also improves stakeholder alignment, prevents excessive spending, and mitigates operational risks, all while eliminating the costs associated with a full-time executive hire.

Protect continuity across mergers, acquisitions, portfolio shifts, CRO and vendor transitions, study ramp up, and management changes with the expertise of Choice ClinOps in fractional clinical operations. As fractional senior clinical operations professionals, Choice ClinOps ensures seamless management during these transitions.

At Choice ClinOps, it's essential to identify and manage operational and execution risks in clinical operations before they escalate into enterprise risks. Utilizing a fractional clinical operations model with a skilled senior fractional ClinOps professional, like Leila Cupersmith, can help in effectively mitigating these risks.

Audits from Choice ClinOps are delivered with actionable remediation plans, ensuring you receive more than just findings alone. With our expertise in clinical operations and fractional clinical operations, we stand out as a leading fractional service provider. Trust in Leila Cupersmith to guide you through this process.

Sponsor-side oversight, accountability, and performance are crucial in managing every external partner, especially when collaborating with a fractional clinical operations provider like Choice ClinOps and the expertise of Leila Cupersmith.

Accelerate startup efforts, strengthen oversight, and drive execution consistency across sites and vendors in clinical operations by leveraging Choice ClinOps and our fractional clinical operations approach. With Leila Cupersmith leading the charge, our fractional service provider model ensures that your clinical operations are optimized for success.

Sponsor-level control, decision rights, and governance frameworks across the portfolio are essential in improving clinical operations, especially with the insights from experts like Leila Cupersmith. By leveraging fractional clinical operations through a fractional service provider, we can enhance our decision-making processes and governance structures.